Meet The Expert 6: UTERINE SARCOMAS
45 slide(s) – 00:17:45 – English – 2007-10-31
Uterine sarcomas are rare tumors (2-5% of all uterine malignancies) and occur primarily in women 40 to 60 years. Patients with uterine sarcomas have a worse prognosis than patients with endometrial carcinomas of similar stage. The overall survival rate is less than 50%, even when the disease is diagnosed at an early stage.
The four major types are carcinosarcomas, leiomyosarcomas, low-grade endometrial stromal sarcomas and undifferentiated sarcomas.
All uterine sarcomas should be staged surgically with cytologic washings, biopsies of any suspicious lesions, hysterectomy, bilateral salpino-oophorectomy, pelvic and paraaortic lymphnode dissection (for carcinosarcomas and undifferentiated sarcomas) and an omentectomy targeted to the risk of the patient. The benefit of surgical lymph node staging is still unclear. Because of the rarity of the tumor patients should be managed by multidisciplinary teams.